CD8A and COVID-19: It has been noted that COVID-19 patients present the dysregulation of cellular immune response following the pro-inflammatory phase, characterized by sustained and substantial decrease in peripheral lymphocyte counts, specifically CD4+ and CD8+ T cells [37,38,132,159,160,161,162].